Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Natural Product (NP) Details

General Information of the NP (ID: NP1549)
Name
Naringenin
Synonyms
5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; 67604-48-2; 4',5,7-Trihydroxyflavanone; Naringenine; (+/-)-Naringenin; naringetol; 480-41-1; salipurpol; (-)-Naringenin; NARIGENIN; Salipurol; 5,7,4'-Trihydroxyflavanone; 93602-28-9; (S)-Naringenin; BE-14348A; NSC 34875; ( inverted exclamation markA)-Naringenin; CHEMBL32571; MLS000738094; MLS000028739; CHEBI:50202; Flavanone, 4',5,7-trihydroxy-; FTVWIRXFELQLPI-UHFFFAOYSA-N; NSC34875; NSC11855; MFCD00006844; SMR000059039; AK122638; NSC 11855; 4',7-Trihydroxyflavanone
    Click to Show/Hide
Species Origin Potentilla discolor ...     Click to Show/Hide
Potentilla discolor
Kingdom: Viridiplantae
Phylum: Streptophyta
Class: Magnoliopsida
Order: Rosales
Family: Rosaceae
Genus: Potentilla
Species: Potentilla discolor
Disease Hepatitis C virus infection [ICD-11: 1E51] Phase 1 [1]
Structure
Click to Download Mol
2D MOL

3D MOL

    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
C15H12O5
PubChem CID
932
Canonical SMILES
C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O
InChI
1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2
InChIKey
FTVWIRXFELQLPI-UHFFFAOYSA-N
CAS Number
CAS 67604-48-2
Herb ID
HBIN036366
ETMC ID
139
SymMap ID
SMIT00202
TCMSP ID
MOL004328
TTD Drug ID
D02ABO
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP
          ABT-737      Ovarian cancer     Click to Show/Hide the Molecular Data of This Drug
                 Augmenting Drug Sensitivity     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Molecule(s)
                    Regulation
Down-regulation Phosphorylation AKT1  Molecule Info 
Pathway MAP
Up-regulation Cleavage CASP3  Molecule Info 
Pathway MAP
Up-regulation Cleavage PARP1  Molecule Info 
Pathway MAP
                    In-vitro Model SGC-7901 CVCL_0520 Human gastric cancer Homo sapiens
                    Experimental
                    Result(s)
ABT-737 in combination with naringenin showed enhanced anticancer effects on gastric cancer cells.
Target and Pathway
Target(s) Aromatase (CYP19A1)  Molecule Info  [3]
Cytochrome P450 1B1 (CYP1B1)  Molecule Info  [4]
Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1)  Molecule Info  [5]
Lactoylglutathione lyase (GLO1)  Molecule Info  [6]
Oestrogen receptor beta (ESR2)  Molecule Info  [7]
BioCyc Superpathway of steroid hormone biosynthesis Click to Show/Hide
2 Estradiol biosynthesis II
3 Estradiol biosynthesis I
4 Superpathway of tryptophan utilization
5 Superpathway of melatonin degradation
6 Melatonin degradation I
7 Methylglyoxal degradation I
KEGG Pathway Steroid hormone biosynthesis Click to Show/Hide
2 Metabolic pathways
3 Ovarian steroidogenesis
4 Tryptophan metabolism
5 Metabolism of xenobiotics by cytochrome P450
6 Chemical carcinogenesis
7 MicroRNAs in cancer
8 Estrogen signaling pathway
9 Prolactin signaling pathway
10 Pyruvate metabolism
NetPath Pathway FSH Signaling Pathway Click to Show/Hide
2 TSH Signaling Pathway
3 IL4 Signaling Pathway
4 TGF_beta_Receptor Signaling Pathway
5 TCR Signaling Pathway
Panther Pathway Androgen/estrogene/progesterone biosynthesis Click to Show/Hide
Pathwhiz Pathway Androgen and Estrogen Metabolism Click to Show/Hide
2 Pyruvaldehyde Degradation
3 Pyruvate Metabolism
Pathway Interaction Database Plasma membrane estrogen receptor signaling Click to Show/Hide
2 Validated nuclear estrogen receptor beta network
3 Validated nuclear estrogen receptor alpha network
Reactome Endogenous sterols Click to Show/Hide
2 The canonical retinoid cycle in rods (twilight vision)
3 Nuclear Receptor transcription pathway
4 Pyruvate metabolism
WikiPathways Metapathway biotransformation Click to Show/Hide
2 Tryptophan metabolism
3 Oxidation by Cytochrome P450
4 Ovarian Infertility Genes
5 Metabolism of steroid hormones and vitamin D
6 FSH signaling pathway
7 Integrated Breast Cancer Pathway
8 Phase 1 - Functionalization of compounds
9 Estrogen metabolism
10 Benzo(a)pyrene metabolism
11 Tamoxifen metabolism
12 Nuclear Receptors Meta-Pathway
13 Estrogen Receptor Pathway
14 Sulindac Metabolic Pathway
15 Arylhydrocarbon receptor (AhR) signaling pathway
16 miR-targeted genes in muscle cell - TarBase
17 miR-targeted genes in lymphocytes - TarBase
18 miR-targeted genes in epithelium - TarBase
19 miR-targeted genes in adipocytes - TarBase
20 Steroid Biosynthesis
21 Prostate Cancer
22 SIDS Susceptibility Pathways
23 Integrated Pancreatic Cancer Pathway
24 Nuclear Receptors
References
Reference 1 ClinicalTrials.gov (NCT01091077) A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV Infection
Reference 2 Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells. Exp Ther Med. 2016 Feb;11(2):669-673.
Reference 3 Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). Bioorg Med Chem Lett. 2010 May 15;20(10):3050-64.
Reference 4 Selective inhibition of methoxyflavonoids on human CYP1B1 activity. Bioorg Med Chem. 2010 Sep 1;18(17):6310-5.
Reference 5 Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries. J Med Chem. 2008 Jul 24;51(14):4188-99.
Reference 6 Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects. Bioorg Med Chem. 2008 Apr 1;16(7):3969-75.
Reference 7 Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen re... J Med Chem. 2006 Dec 14;49(25):7357-65.
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China